Crinetics Pharmaceuticals Inc Stock
Crinetics Pharmaceuticals Inc Stock price
Key metrics
| Market capitalization | $2.69b |
| Enterprise Value | $1.38b |
| P/E (TTM) P/E ratio | negative |
| EV/FCF (TTM) EV/FCF | negative |
| P/B ratio (TTM) P/B ratio | 2.03 |
| Revenue (TTM) Revenue | $0.00 |
| EBIT (operating result TTM) EBIT | $-339.89m |
| Free Cash Flow (TTM) Free Cash Flow | $-229.81m |
| Cash position | $1.35b |
Is Crinetics Pharmaceuticals Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.
Crinetics Pharmaceuticals Inc Stock Analysis
Analyst Opinions
17 Analysts have issued a Crinetics Pharmaceuticals Inc forecast:
Analyst Opinions
17 Analysts have issued a Crinetics Pharmaceuticals Inc forecast:
Financial data from Crinetics Pharmaceuticals Inc
| Dec '24 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | -2.79 -2.79 |
110%
110%
|
|
| EBITDA | -337 -337 |
50%
50%
|
EBIT (Operating Income) EBIT | -340 -340 |
50%
50%
|
| Net Profit | -298 -298 |
39%
39%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Crinetics Pharmaceuticals Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Crinetics Pharmaceuticals Inc Stock News
Company Profile
Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly. The firm is also developing other oral nonpeptide somatostatin agonists for neuroendocrine tumors and hyperinsulinism, as well as an oral nonpeptide ACTH antagonist for the treatment of Cushing's disease. The company was founded by R. Scott Struthers, Yun-Fei Zhu and Stephen F. Betz in 2008 and is headquartered in San Diego, CA.
| Head office | United States |
| CEO | Scott Struthers |
| Employees | 437 |
| Founded | 2008 |
| Website | www.crinetics.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
